About Jimmy El Hokayem, PhD

This author has not yet filled in any details.
So far Jimmy El Hokayem, PhD has created 14 blog entries.

Are Cannabinoid-Derived Drugs the Future of Medicine?

2019-05-14T10:40:43+00:00By |Categories: Blog Articles|Tags: |

Less than a year ago, FDA approved the first cannabinoid-derived drug, Epidiolex. It's a pivotal development for a few reasons: It's the first FDA-approved drug to contain cannabidiol (CBD), a chemical component of the Cannabis sativa plant, aka, marijuana.It treats Dravet syndrome and Lennox-Gastaut syndrome, two rare and severe forms of epilepsy [...]

Is Gut Microbiome Behind Our Next Breakthrough Therapy?

2019-05-03T12:54:44+00:00By |Categories: Blog Articles|Tags: , , |

"Microbiome" has become a consumer product buzzword, found in advertisements for soap and dozens of foods that contain "friendly bacteria." Meanwhile, the scientific community is discovering new connections between the microbiome and our physical and mental health. Manipulating the microbiome may, in time, lead to cures and more targeted treatments. The microbiome–gut–brain [...]

Cellular Therapy in Neurological Diseases: The Latest Advances and Challenges

2019-04-17T14:54:21+00:00By |Categories: Blog Articles|Tags: , |

Neurological disorders and diseases affect all ages and ethnicities, and most result in long-term disability and irreversible conditions. A paper published in the Annals of Neurology reports the nine most common neurological diseases cost the United States nearly $800 billion a year. As our population ages and the prevalence of conditions such as Alzheimer's [...]

Advances in Non-Opioid Options for Post-Operative Pain Management

2019-04-17T11:25:25+00:00By |Categories: Blog Articles|Tags: , |

In a statement last August, departing FDA Commissioner Scott Gottlieb outlined several steps the agency had planned to further address the opioid crisis. Part of that approach, he wrote, includes supporting development of non-opioid, non-addictive alternatives for acute and chronic pain. The FDA plans to outline a path for developing extended-release local [...]

Introducing Biorasi’s Center of Excellence: Neurology and Regenerative Medicine

2019-04-25T15:21:36+00:00By |Categories: Blog Articles|Tags: , |

Advances in stroke management, the first cannabinoid-derived drug approved, new therapeutics for progressive multiple sclerosis, early signs of successful treatment of diabetes and myocardial infarct via stem cell therapy…these are a few of the many neurology and regenerative medicine developments we've seen over the past year. As researchers delve deeper into genetics, [...]

When Virtual Trials Are Not the Answer

2019-03-27T12:21:33+00:00By |Categories: Blog Articles|Tags: , |

Next to cost, patient recruitment, enrollment, and retention are top concerns for sponsors, sites, and others involved in clinical trials. Will virtual clinical trials ease these challenges and reduce the 90% failure rate? Not yet. What do we mean by virtual clinical trials? Virtual clinical trials, or siteless clinical trials, use videoconferencing, [...]

Bolstering Enrollment in Parkinson’s Trials: Patient Support Groups

2018-05-29T11:56:31+00:00By |Categories: Blog Articles|

Novel treatments, accurate biomarkers and efficient diagnostic tests are direly needed in the fight against Parkinson’s Disease (PD), the second leading neurodegenerative disease in the world. One major avenue to support biomedical discoveries in the PD realm, paving the path to reach patients, is to bolster PD clinical research trials, yet only [...]

Special Considerations for Clinical Trials in Neurological Diseases

2018-05-29T10:15:21+00:00By |Categories: Blog Articles|Tags: |

Clinical trials in neurological diseases often mirror the complexity of the disease itself. Hence, a team tackling this type of clinical trial should make a number of assumptions, some of which are ubiquitous among other therapeutic areas while others are unique for this specific field. In this blog, we will tackle some [...]

Non-Traditional Trial Recruitment Strategies for Non-Traditional Populations

2018-05-09T14:00:21+00:00By |Categories: Blog Articles|

Innovative and out of the box methods are often required for the recruitment of challenging populations in clinical trials that would otherwise fail miserably when using conventional recruitment strategies. In this arena, Biorasi has positioned itself as a pioneer and repeatedly demonstrated enormous capabilities in establishing smart recruiting approaches for difficult to [...]

Stem Cells?! What are they? How do they work?

2019-01-09T13:54:13+00:00By |Categories: Blog Articles|Tags: |

Introduction Stem Cell Therapy is one of the most important biomedical discoveries in recent history, with far-reaching potential effects on a wide range on individuals afflicted with numerous diseases. Nonetheless, basic knowledge about Stem Cells - their sources, characteristics and therapeutic mechanisms -  still elude a large portion of the public. Here, [...]

Stem Cells: Myths and Misconceptions in the Public Eye

2019-01-09T13:54:13+00:00By |Categories: Blog Articles|Tags: |

Stem Cell therapy constitutes one of the most hailed advents in medicine for its potential in treating many of the chronic and difficult diseases like Traumatic Brain Injury, Diabetes and Cancer. However, a huge cloud of myths and misconceptions surrounds this topic, alienating the public from embracing them as a viable option [...]

Download our Precision Medicine Checklist

Complete the form below to receive a link to download this checklist

Schedule a call with one of our experts today

Let us know how we can help with your clinical trials